Humanized Mouse and Rat Model Market Is Expected To Reach $172.83 million by 2025

1
Humanized Mouse and Rat Model Market Is Expected
To Reach 172.83 million by 2025
Global Humanized Mouse and Rat Model market in
terms of revenue is expected to reach
172.83million by 2025 at a CAGR of 9.13 from
2018 to 2025 as per new market research report
titled Global Humanized Mouse and Rat Model
Market (Bymodelstype- cell-based models, and
genetic models. By application- hematopoiesis,
oncology, toxicology, autoimmunity, infection
diseases, and others. By end-user- contract
research organization, the pharmaceutical
industry, and others) - global industry
analysis, size, share, growth, trends, and
forecast, 2017 2025, by Sheer Analytics
Insights Pvt. Ltd.
2
In the laboratories for modeling, the human
biology and diseases humanized mouse and rat
models are used. They are also known by Knocking
model and are used as a replacement of mouse
gene by human gene or genomic sequence. It is
termed as knocking as this technology consist of
the deletion of a gene from the mouse genome and
then it is replaced by human ortholog or
gene. Browse Full report at Global Humanized
Mouse and Rat Model Market In rising number of
application areas for humanized mouse rat
model which includes infection diseases, oncology
among others is the prime factor for the growth
of this market. Investment by the key players in
ensuring better healthcare facilities is one of
the most influencing factors for making the
market more demanding during the estimated
period. Increasing occurrence of cancer
diseases, surge in the production of monoclonal
antibodies along with the stem cell exploration
are some other factors contributing towards the
growth of the humanized mouse rat model
market. From the past few years, the global
humanized mouse and rat market is dominated by
North-America. The major reasons for which the
demand for humanized mouse and rat model is
increasing are the growth in monoclonal antibody
production, preclinical activities by CROs and
pharmaceutical RD. The market is growing also
owing to the continuous and responsible use of
animals which is ensured by the animal care
organizations.
3
Furthermore, it is estimated that the growth of
the humanized mouse and rat model market will
increase in Asia- Pacific owing to the
international alliances for research and
development activities conducted in China. In
this alliance, China has taken initiatives for
reducing the approval time for drugs, mandatory
animal testing for every type of pharmaceutical
drug along with cosmetics. The demand for this
market is also
increasing in India owing to the growth of the
biomedical industry and the development of
bio-clusters. While emphasizing on the importance
of mice in cancer research, Charles Hewett,
Jackson Lab's former executive vice president
and chief operating officer mentioned, Mice are
small, relatively speaking, they're inexpensive
to house, they're inexpensive to feed and, best
of all perhaps, they breed incredibly quickly.
Jax pioneered the use of mice in genetic
research and we believe very strongly in the
importance of this work work to solve the
critical problems of human health and to
identify and test better treatments." In the
recent market research report that was published
by Sheer Analytics Insights, the global
humanized mouse and rat model market has been
segmented based on the models type,
application, and end-user. Based on the model's
type, the market has been analyzed as cell-based
models and genetic models. The cell-based models
further sub-segmented into BLT
model, CD34, and PBMC. The major end-user of globa
l humanized mouse and rat model
market includes contract
4

• research organization, the pharmaceutical
  industry, and others. Moving forward, the market
  is further segmented by an application such as
  hematopoiesis, oncology, toxicology,
  autoimmunity, infection diseases, and others.
  Geographically, global humanized mouse and rat
  model market segmented into North America,
  Middle East Africa, Asia-Pacific, and Latin
  America.
• List of Companies Covered
• Axenis S.A.S.,
• Crown Bioscience, Inc.,
• Champions Oncology,
• Charles River Laboratories,
• GenOway S.A.,
• Harbour Antibodies BV,
• Ingenious Targeting Laboratory, and
• Taconic Biotechnology Co.
• Global Artificial Graphite Market and its
  segmentation By Models Type
• Cell-based models
• BLT model
• CD34
• PBMC

5

• Genetic models
• By Application Type
• Hematopoiesis
• Oncology
• Toxicology
• Autoimmunity
• Infection diseases
• Others
• By End-User Type
• Contract research organization
• Pharmaceutical industry
• Others
• By Geography Type
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
• To know more about this study, request a free
  sample report _at_ https//www.sheeranalyticsandinsi
  ghts.com/request- sample/global-humanized-mouse-a
  nd-rat-model-market-21

6
About Us Sheer Analytics and Insights as firm is
created to balance between client requirements
without compromising the core values of Market
research in terms of quality, factual
correctness, market awareness and analysis. SAI
goes back to the root of Market Research in
terms of TAM (Total Available Market) and PAM
(Potential Available Market) and assess the same
quantifying all Push and Pull factors. Contact
us Name Abhigyan Sengupta (Global sales
Manager) Ph - 91-33-4600-9199 RDB Boulevard,
8th Floor, Plot K 1, Sector 5, Block EP and GP,
Kolkata 700091, India. Email sales_at_sheeranalytics
andinsights.com Website https//www.sheeranalytic
sandinsights.com/